Imaging Chemicals Market Report 2025

The imaging chemicals market size has grown strongly in recent years. It will grow from $26.63 billion in 2024 to $28.31 billion in 2025 at a compound annual growth rate (CAGR) of 6.3%. The growth in the historic period can be attributed to consumer adoption of photography, graphic arts and printing, medical imaging, industrial imaging applications, demand for high-quality prints, film-based cinematography.

The imaging chemicals market size is expected to see strong growth in the next few years. It will grow to $37.57 billion in 2029 at a compound annual growth rate (CAGR) of 7.3%. The growth in the forecast period can be attributed to printed electronics, increased demand for security imaging, demand for sustainable solutions, bio-based and renewable resources, functional imaging materials. Major trends in the forecast period include digital transformation in imaging, advanced photographic printing technologies, customization for specialized applications, smart imaging materials, collaborations for innovation.

The rising incidence of cancer and brain disorders is fueling the growth of the imaging chemicals market. Cancer encompasses a wide range of diseases marked by the uncontrolled division of abnormal cells, while brain disorders involve diseases affecting the central and peripheral nervous systems. The increasing prevalence of these conditions is boosting the demand for imaging chemicals, which provide advantages such as real-time monitoring, determining the stage and exact location of tumors to assist in surgical guidance and other treatment modalities, and visualizing cellular activity. For example, in October 2023, the EU Science Hub, a Belgium-based site of the European Commission's Joint Research Centre, reported a 2.3% rise in new cancer cases from 2020 to 2.74 million in 2022. Additionally, cancer mortality saw a 2.4% increase between 2010 and 2020. According to the World Federation of Neurology in October 2023, brain disorders rank as the second leading cause of death worldwide and the primary cause of disability. Consequently, the growing prevalence of cancer and brain disorders is expected to drive the imaging chemicals market forward.

The growing incidence of chronic diseases is anticipated to further propel the growth of the imaging chemicals market in the coming years. Chronic diseases, also referred to as non-communicable diseases (NCDs), are long-lasting medical conditions defined by their persistent nature. Imaging chemicals are essential in the diagnosis, monitoring, and management of chronic diseases, functioning as contrast agents or tracers in various imaging techniques that enable healthcare providers to visualize internal structures, identify abnormalities, and evaluate the progression of these conditions. For instance, in March 2022, the Australian Bureau of Statistics, an Australia-based organization responsible for data collection and analysis, revealed that nearly three-quarters (78.6%) of Australians have at least one long-term health issue, with almost half of the population (46.6% or 11.6 million people) affected by at least one chronic disease. Therefore, the increasing prevalence of chronic diseases is driving the imaging chemicals market.

A prominent trend in the imaging chemicals market is technological advancement. Major market players are focusing on developing advanced technologies to maintain their competitive edge. For example, Guerbet Group launched Elucirem (gadopiclenol) injection, a latest-generation gadolinium-based contrast agent (GBCA) for magnetic resonance imaging (MRI). This innovation offers the highest relaxivity in its category and requires half the gadolinium dosage of traditional GBCAs. The injection facilitates the detection and visualization of lesions in various body parts, addressing concerns about gadolinium exposure.

Leading companies in the imaging chemicals market are concentrating on establishing new ventures in imaging chemicals to enhance their product offerings and foster innovation within the industry. This strategy allows them to utilize advanced technologies and address the evolving requirements of various applications, including medical imaging, printing, and electronic imaging. For example, in July 2024, Chameleon Aaron Chemical Pvt. Ltd., an India-based chemical firm, launched a new venture dedicated to imaging chemicals in Maharashtra, investing ₹5 crore in the initiative. This project, situated in Kaire, Raigarh, aims to boost the production and supply of specialized chemicals essential for diverse imaging applications critical to sectors such as photography, medical imaging, and printing.

In August 2022, Saati Advanced Chemicals LLC, a US-based company wholly owned by Saati’s USA subsidiary, Saati Americas Corp, announced the acquisition of Ikonics Corporation for an undisclosed sum. This acquisition represents a further step in SAATI's growth strategy and development efforts. Ikonics Corporation is a US-based firm that provides screen preparation chemicals, digital pre-press products, direct emulsions, and specialty inks.

Major companies operating in the imaging chemicals market include Eastman Kodak Company, Agfa-Gevaert NV, Altana AG, BASF SE, Clariant Chemical Company, DIC Corporation, Dow Chemical Company, Flint Group S.A., FUJIFILM Holdings Corporation, Hubergroup Deutschland GmbH, Kao Corporation, Kodak Alaris Inc., Qingdao Scienoc Chemical Co., Sakata Inx Corp., Siegwerk Druckfarben AG & Co. KGaA, T&K TOKA Corporation, Toyo Ink SC Holdings Co. Ltd., Wikoff Color Corporation, Dymax Corporation, Evonik Industries AG, Kemira Oyj, Merck Co. & KGaA.

Asia-Pacific was the largest region in the imaging chemicals market in 2024. The regions covered in the imaging chemicals market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the imaging chemicals market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

Imaging chemicals are substances utilized in the development or output of images, playing a crucial role in various applications such as printing package labels and producing diagnostic images.

The main product types within the category of imaging chemicals include imaging agents and toners, printing inks, and imaging developers. Imaging agents and toners are particularly important for visualizing internal organ function, facilitating clinical analysis, and supporting medical procedures. These chemicals find applications in diverse fields, including medical diagnostics, packaging and printing, textile processing, mining, and others.

The imaging chemicals market research report is one of a series of new reports that provides imaging chemicals market statistics, including the imaging chemicals industry global market size, regional shares, competitors with imaging chemicals market share, detailed imaging chemicals market segments, market trends, and opportunities, and any further data you may need to thrive in the imaging chemicals industry. This imaging chemicals market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The imaging chemicals market consists of sales of binders, carriers, pigments, and additives used for imaging purposes. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 3-5 business days.